It can take up to six years to build up a body of evidence to support a new drug candidate for commercial development. That’s a long time. At twoXAR, we are turning those years into minutes. Whether we are using your data to generate new drug candidates for a specific disease or assessing the efficacy of existing therapeutics, we can help. Using big data and patent-pending algorithms, we radically reduce the time it takes to find new drug candidates and assess their efficacy. Using our DUMA™ Drug Discovery platform we evaluate large public and proprietary datasets to identify and rank high probability drug-disease matches orders of magnitude faster than wet-lab approaches. These matches can be used to cross-validate clinical research, repurpose existing medicines, or identify novel drug candidates for further clinical testing.
Palo Alto, US
Size (employees)
16 (est)-5%
twoXAR was founded in 2014 and is headquartered in Palo Alto, US
Report incorrect company information

twoXAR Office Locations

twoXAR has an office in Palo Alto
Palo Alto, US (HQ)
221 Forest Ave
Show all (1)
Report incorrect company information

twoXAR Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$14.3 m

Latest funding size

$10 m

Time since last funding

2 months ago


twoXAR's latest funding round in March 2018 was reported to be $10 m. In total, twoXAR has raised $14.3 m
Show all financial metrics
Report incorrect company information